Related Experiment Videos
Two Chain "Insulin/Insulin-like Growth Factor-I" Hybrids
Yue-Hua Tang1, Heng-Ran Cui, You-Min Feng
1State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry, Academia Sinica, Shanghai 200031, China.
Summary
Researchers created novel insulin-like growth factor-I (IGF-I) hybrid molecules. These hybrids demonstrated full insulin activity in vivo, indicating modifications do not impact insulin function.
Area of Science:
- Biochemistry
- Molecular Biology
- Endocrinology
Background:
- Insulin and Insulin-like Growth Factor-I (IGF-I) are crucial peptide hormones involved in metabolic regulation and growth.
- Understanding the structure-activity relationship of these hormones is key to developing novel therapeutic agents.
Purpose of the Study:
- To synthesize and characterize novel hybrid molecules combining insulin and IGF-I sequences.
- To evaluate the in vivo biological activity of these hybrid molecules compared to native insulin.
Main Methods:
- Enzymatic semisynthesis was employed to create two-chain "Insulin/Insulin-like Growth Factor-I" hybrids: Ins/IGF-I(8) and Ins/IGF-I(11).
- Desoctapeptide insulin (DOI) was used as a starting material, along with chemically synthesized octapeptide and undecapeptide fragments of IGF-I (sequences 22-29 and 22-32).
Main Results:
- The synthesized hybrid molecules, Ins/IGF-I(8) and Ins/IGF-I(11), were successfully obtained.
- In vivo studies demonstrated that these hybrid molecules retain the full biological activity of native insulin.
- Specific modifications, including amino acid substitutions (B27Thr to Asn, B30Ala to Thr), altered sequence orders (B25/B26, B28/B29), and B30 tripeptide extension (Gly-Tyr-Gly), did not diminish insulin activity.
Conclusions:
- The study successfully generated novel insulin-IGF-I hybrid molecules.
- These findings indicate that significant modifications to the insulin B-chain, including substitutions and extensions, can be tolerated without loss of insulin activity.
- This research provides insights into the structural determinants of insulin's biological function and opens avenues for protein engineering in endocrinology.